Use of antenatal corticosteroids in the management of preterm delivery

Loading...
Thumbnail Image

Date

Journal Title

Journal ISSN

Volume Title

Publisher

Thieme Medical Publishers, Inc.

Abstract

Objective This narrative review of the literature explores the current evidence and recommendations in favor of antenatal corticosteroids use during impending preterm deliveries as well as related issues and concerns. Study Design Synthesis of findings from published medical literature on antenatal corticosteroids and prematurity, retrieved from searches of computerized databases and authoritative texts. Results It is now recognized that an intramuscular course of betamethasone or dexamethasone given to a woman expected to deliver preterm not only accelerates pulmonary epithelial development but also matures other organ systems, significantly decreasing the chances of neonatal morbidities and increasing chances of survival. Conclusion There remain uncertainties over the efficacy of the established protocol in populations such as the very early preterm, the late preterm, and multiple gestations. Alternative regimens remain controversial because of fear of adverse effects and doubts regarding whether benefits outweigh risks. Copyright © 2015 by Thieme Medical Publishers, Inc.

Description

Keywords

Antenatal corticosteroids, Betamethasone, Dexamethasone, Prematurity, Female, Fetal organ maturity, Gestational age, Glucocorticoids, Humans, Infant, newborn, Infant, premature, Pregnancy, Pregnancy complications, Premature birth, Randomized controlled trials as topic, Respiratory distress syndrome, newborn, Corticosteroid, Glucocorticoid, Corticosteroid therapy, Human, Multiple pregnancy, Newborn morbidity, Premature labor, Prenatal care, Priority journal, Review, Drug effects, Fetus maturity, Growth, development and aging, Newborn, Randomized controlled trial (topic)

Citation

Endorsement

Review

Supplemented By

Referenced By